THYROID-STIMULATING IMMUNOGLOBULINS IN OPHTHALMIC GRAVES'DISEASE

1 March 1977

journal article
research article
Published by Wiley in Clinical Endocrinology

Vol. 6 (3) , 207-211
https://doi.org/10.1111/j.1365-2265.1977.tb03316.x

Abstract

Thyroid-stimulating immunoglobulins (TSI) were detected by receptor assay in the sera of 43% of patients with ophthalmic Graves'' disease. Comparison of the receptor assay studies with thyroid function tests indicated that in several patients the antibodies detected by receptor assay were biologically inactive. In other patients, thyroid function appeared to be under TSI control with hyperthyroidism prevented by autoimmune destruction of the thyroid.

This publication has 14 references indexed in Scilit:

Assessment of thyroid hormone assays.
Journal of Clinical Pathology, 1976
RELATION OF THYROID-STIMULATING IMMUNOGLOBULINS TO THYROID FUNCTION AND EFFECTS OF SURGERY, RADIOIODINE, AND ANTITHYROID DRUGS
The Lancet, 1975
THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE
The Lancet, 1974
Evaluation of a tanned red cell technique for thyroid microsomal antibodies
Journal of Clinical Pathology, 1973
Radioimmunoassay of Triiodothyronine in Unextracted Human Serum
BMJ, 1973
THE THYROTROPHIN-RELEASING HORMONE TEST IN DISEASES OF THE PITUITARY AND HYPOTHALAMUS
The Lancet, 1972
THYROTROPHIN-RELEASING HORMONE AS A THYROID-FUNCTION TEST
The Lancet, 1971
Radioimmunoassay of Human Serum Thyrotrophin
BMJ, 1971
Evaluation of Thyopac-3 Test in the In-vitro Assessment of Thyroid Function
BMJ, 1970
OPHTHALMIC GRAVES' DISEASE: Diagnosis and Pathogenesis
The Lancet, 1970